Literature DB >> 20200373

Intraperitoneal meropenem administration: a possible alternative to the intravenous route.

C Van Ende, M Tintillier, C Cuvelier, G Migali, J M Pochet.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20200373     DOI： 10.3747/pdi.2009.00052

Source DB:  PubMed          Journal:  Perit Dial Int        ISSN： 0896-8608            Impact factor:   1.756


× No keyword cloud information.
  5 in total

1.  Intraperitoneal compared with intravenous meropenem for peritoneal dialysis-related peritonitis.

Authors:  P J Vlaar; M van Hulst; C A Benne; W M Janssen
Journal:  Perit Dial Int       Date:  2013 Nov-Dec       Impact factor: 1.756

2.  An Open, Randomized, Single-Center, Crossover Pharmacokinetic Study of Meropenem after Intraperitoneal and Intravenous Administration in Patients Receiving Automated Peritoneal Dialysis.

Authors:  Martin Wiesholzer; Petra Pichler; Gottfried Reznicek; Michaela Wimmer; Manuel Kussmann; Peter Balcke; Heinz Burgmann; Markus Zeitlinger; Wolfgang Poeppl
Journal:  Antimicrob Agents Chemother       Date:  2016-04-22       Impact factor: 5.191

3.  Influence of Different Peritoneal Dialysis Fluids on the In Vitro Activity of Cefepime, Ciprofloxacin, Ertapenem, Meropenem and Tobramycin Against Escherichia Coli.

Authors:  Manuel Kussmann; Linda Schuster; Sarah Wrenger; Petra Pichler; Gottfried Reznicek; Heinz Burgmann; Wolfgang Poeppl; Markus Zeitlinger; Martin Wiesholzer
Journal:  Perit Dial Int       Date:  2016-09-28       Impact factor: 1.756

4.  Infections Caused by Antimicrobial Drug-Resistant Saprophytic Gram-Negative Bacteria in the Environment.

Authors:  Eva Raphael; Lee W Riley
Journal:  Front Med (Lausanne)       Date:  2017-10-30

5.  Extended spectrum beta lactamase peritonitis: Time for innovation?

Authors:  R Sinha; A Bhakta
Journal:  Indian J Nephrol       Date:  2012-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.